Search Results - "Maslov, Dmitry A."

Refine Results
  1. 1

    Mutations in Efflux Pump Rv1258c (Tap) Cause Resistance to Pyrazinamide, Isoniazid, and Streptomycin in M. tuberculosis by Liu, Jiayun, Shi, Wanliang, Zhang, Shuo, Hao, Xiaoke, Maslov, Dmitry A, Shur, Kirill V, Bekker, Olga B, Danilenko, Valery N, Zhang, Ying

    Published in Frontiers in microbiology (19-02-2019)
    “…Although drug resistance in is mainly caused by mutations in drug activating enzymes or drug targets, there is increasing interest in the possible role of…”
    Get full text
    Journal Article
  2. 2

    Transcriptomic Profile of Mycobacterium smegmatis in Response to an Imidazo[1,2-b][1,2,4,5]tetrazine Reveals Its Possible Impact on Iron Metabolism by Vatlin, Aleksey A., Shitikov, Egor A., Shahbaaz, Mohd, Bespiatykh, Dmitry A., Klimina, Ksenia M., Christoffels, Alan, Danilenko, Valery N., Maslov, Dmitry A.

    Published in Frontiers in microbiology (04-08-2021)
    “…Tuberculosis (TB), caused by the Mycobacterium tuberculosis complex bacteria, is one of the most pressing health problems. The development of new drugs and new…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Kanamycin and Ofloxacin Activate the Intrinsic Resistance to Multiple Antibiotics in Mycobacterium smegmatis by Vatlin, Aleksey A, Bekker, Olga B, Shur, Kirill V, Ilyasov, Rustem A, Shatrov, Petr A, Maslov, Dmitry A, Danilenko, Valery N

    Published in Biology (Basel, Switzerland) (27-03-2023)
    “…Drug resistance (DR) in is the main problem in fighting tuberculosis (TB). This pathogenic bacterium has several types of DR implementation: acquired and…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Repurposing Based Identification of Novel Inhibitors against MmpS5-MmpL5 Efflux Pump of Mycobacterium smegmatis : A Combined In Silico and In Vitro Study by Shahbaaz, Mohd, Maslov, Dmitry A, Vatlin, Aleksey A, Danilenko, Valery N, Grishina, Maria, Christoffels, Alan

    Published in Biomedicines (31-01-2022)
    “…In the current era of a pandemic, infections of COVID-19 and Tuberculosis (TB) enhance the detrimental effects of both diseases in suffering individuals. The…”
    Get full text
    Journal Article
  8. 8

    MmpS5-MmpL5 Transporters Provide Mycobacterium smegmatis Resistance to imidazo[1,2- b ][1,2,4,5]tetrazines by Maslov, Dmitry A, Shur, Kirill V, Vatlin, Aleksey A, Danilenko, Valery N

    Published in Pathogens (Basel) (28-02-2020)
    “…The emergence and spread of drug-resistant strains (including MDR, XDR, and TDR) force scientists worldwide to search for new anti-tuberculosis drugs. We have…”
    Get full text
    Journal Article
  9. 9

    Identification of Mutations Conferring Tryptanthrin Resistance to Mycobacterium smegmatis by Frolova, Svetlana G, Klimina, Ksenia M, Kumar, Ravinder, Vatlin, Aleksey A, Salunke, Deepak B, Kendrekar, Pravin, Danilenko, Valery N, Maslov, Dmitry A

    Published in Antibiotics (Basel) (23-12-2020)
    “…Tuberculosis (TB), caused by , is a global burden, responsible for over 1 million deaths annually. The emergence and spread of drug-resistant strains (MDR-,…”
    Get full text
    Journal Article
  10. 10

    Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960 by Maslov, Dmitry A, Zaĭchikova, Marina V, Chernousova, Larisa N, Shur, Kirill V, Bekker, Olga B, Smirnova, Tatiana G, Larionova, Elena E, Andreevskaya, Sofya N, Zhang, Ying, Danilenko, Valery N

    Published in Tuberculosis (Edinburgh, Scotland) (01-09-2015)
    “…Summary Resistance to pyrazinamide (PZA) may impact clinical outcome of anti-tuberculosis chemotherapy. PZA susceptibility testing using MGIT 960 is not…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Transcriptomic dataset of Mycolicibacterium smegmatis exposed to an imidazo[1,2-b][1,2,4,5]tetrazine by Vatlin, Aleksey A., Klimina, Ksenia M., Frolova, Svetlana G., Danilenko, Valery N., Maslov, Dmitry A.

    Published in Data in brief (01-08-2020)
    “…Deciphering the mechanism of action of novel anti-tuberculosis compounds is a key step in the drug development process. We have previously described a number…”
    Get full text
    Journal Article
  13. 13

    Sterilizing Effects of Novel Regimens Containing TB47, Clofazimine, and Linezolid in a Murine Model of Tuberculosis by Yu, Wei, Yusuf, Buhari, Wang, Shuai, Tian, Xirong, Hameed, H M Adnan, Lu, Zhili, Chiwala, Gift, Alam, Md Shah, Cook, Gregory M, Maslov, Dmitry A, Zhong, Nanshan, Zhang, Tianyu

    Published in Antimicrobial agents and chemotherapy (17-09-2021)
    “…TB47, a new drug candidate targeting QcrB in the electron transport chain, has shown a unique synergistic activity with clofazimine and forms a highly…”
    Get full text
    Journal Article
  14. 14

    Transcriptional regulation of drug resistance mechanisms in Salmonella: where we stand and what we need to know by Shaheen, Aqsa, Tariq, Anam, Shehzad, Aamir, Iqbal, Mazhar, Mirza, Osman, Maslov, Dmitry A., Rahman, Moazur

    “…Salmonellae have evolved a wide range of molecular mechanisms to neutralize the effect of antibiotics and evade the host immune system response. These…”
    Get full text
    Journal Article
  15. 15

    Synthesis and antimycobacterial activity of imidazo[1,2-b][1,2,4,5]tetrazines by Maslov, Dmitry A., Korotina, Anna V., Shur, Kirill V., Vatlin, Alexey A., Bekker, Olga B., Tolshchina, Svetlana G., Ishmetova, Rashida I., Ignatenko, Nina K., Rusinov, Gennady L., Charushin, Valery N., Danilenko, Valery N.

    Published in European journal of medicinal chemistry (15-09-2019)
    “…Tuberculosis (TB) has recently become the leading killer among infectious diseases. Multidrug and extensively drug-resistant Mycobacterium tuberculosis strains…”
    Get full text
    Journal Article
  16. 16

    CRISPR-Cas Systems: Prospects for Use in Medicine by Zaychikova, Marina V., Danilenko, Valery N., Maslov, Dmitry A.

    Published in Applied sciences (01-12-2020)
    “…CRISPR-Cas systems, widespread in bacteria and archaea, are mainly responsible for adaptive cellular immunity against exogenous DNA (plasmid and phage)…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Draft Genome Sequences of 12 Mycolicibacterium smegmatis Strains Resistant to Imidazo[1,2- b ][1,2,4,5]Tetrazines by Vatlin, Aleksey A, Shur, Kirill V, Danilenko, Valery N, Maslov, Dmitry A

    Published in Microbiology resource announcements (18-04-2019)
    “…Here, we report 12 draft genome sequences of mutant strains resistant to imidazo[1,2- ][1,2,4,5]tetrazines, which are antituberculosis drug candidates. We have…”
    Get full text
    Journal Article
  19. 19

    Sequencing and Analysis of Three Mycobacterium tuberculosis Genomes of the B0/N-90 Sublineage by Zakharevich, Natalia V., Zaychikova, Marina V., Shur, Kirill V., Bekker, Olga B., Maslov, Dmitry A., Danilenko, Valery N.

    Published in Microbiology resource announcements (26-09-2019)
    “…We report the draft genome sequences of three Mycobacterium tuberculosis isolates belonging to the B0/N-90 sublineage, EKB34, EKB53, and EKB79. The B0/N-90…”
    Get full text
    Journal Article
  20. 20

    Draft Genome Sequences of Mycobacterium tuberculosis Clinical Isolates from the Ural Region of Russia That Carry the pks15/1 Gene by Shur, Kirill V, Zakharevich, Natalia V, Akimova, Natalia I, Yunes, Roman A, Frolova, Svetlana G, Maslov, Dmitry A, Danilenko, Valery N

    Published in Microbiology resource announcements (05-12-2019)
    “…Here, we report the draft genome sequences of 15 isolates of the Beijing-B0/W-148 sublineage that carry a 7-bp insertion within the gene, which leads to the…”
    Get full text
    Journal Article